Chartwell Molecules Company Profile

What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?

CHARTWELL MOLECULES has twenty-one approved drugs.

Summary for Chartwell Molecules

US Patents:	0
Tradenames:	16
Ingredients:	16
NDAs:	21

Drugs and US Patents for Chartwell Molecules

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecules	METRONIDAZOLE	metronidazole	TABLET;ORAL	018930-001	Aug 18, 1983		DISCN	No	No
Chartwell Molecules	ETODOLAC	etodolac	TABLET;ORAL	074841-001	Jun 27, 1997		DISCN	No	No
Chartwell Molecules	ETODOLAC	etodolac	CAPSULE;ORAL	074842-002	Jul 17, 1997		DISCN	No	No
Chartwell Molecules	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	078060-002	Jan 25, 2007	AB	RX	No	No
Chartwell Molecules	CIMETIDINE	cimetidine	TABLET;ORAL	074329-002	May 17, 1994		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Chartwell
• Chartwell Injectable
• Chartwell Molecular
• Chartwell Molecules
• Chartwell Pharma